Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias.

Shah, Nirali N

Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. [electronic resource] - Pediatric blood & cancer Jun 2016 - 997-1005 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural

1545-5017

10.1002/pbc.25937 doi


Adolescent
Antineoplastic Agents, Phytogenic--administration & dosage
Child
Child, Preschool
Female
Humans
Liposomes
Male
Maximum Tolerated Dose
Neoplasms--drug therapy
Registries
Vincristine--administration & dosage
Young Adult